These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33654234)

  • 21. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular hypertrophy and antihypertensive therapy.
    Messerli FH; Oren S; Grossman E
    Drugs; 1988; 35 Suppl 5():27-33. PubMed ID: 2975215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy: impact of calcium channel blocker therapy.
    Messerli FH
    Am J Med; 1991 May; 90(5A):27S-31S. PubMed ID: 2039017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of left ventricular hypertrophy is a key goal of hypertension management.
    Zhang R; Crump J; Reisin E
    Curr Hypertens Rep; 2003 Aug; 5(4):301-8. PubMed ID: 12844464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic impact of regression of left ventricular hypertrophy by antihypertensive drugs.
    Eagle KA; Blank DJ; Aguiar E; Firth LM
    J Hum Hypertens; 1993 Aug; 7(4):341-51. PubMed ID: 8105082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of hypertension in patients with left ventricular hypertrophy.
    Cuspidi C; Sala C; Zanchetti A
    Curr Hypertens Rep; 2007 Dec; 9(6):498-505. PubMed ID: 18367014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
    Minatoguchi S; Kawasaki M; Tanaka R; Yoshizane T; Ono K; Saeki M; Nagaya M; Sato H; Nishigaki K; Noda T; Zile MR; Minatoguchi S
    Heart Vessels; 2017 Oct; 32(10):1202-1213. PubMed ID: 28638961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.
    Morisco C; Argenziano L; Tozzi N; Mele AF; Ricciardelli B; Condorelli G; Trimarco B
    Drugs; 1993; 46 Suppl 2():88-94. PubMed ID: 7512489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
    Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents.
    Schlaich MP; Schmieder RE
    Am J Hypertens; 1998 Nov; 11(11 Pt 1):1394-404. PubMed ID: 9832187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta blockers & left ventricular hypertrophy regression.
    George T; Ajit MS; Abraham G
    Indian Heart J; 2010; 62(2):139-42. PubMed ID: 21180305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and left ventricular hypertrophy: is drug therapy beneficial?
    Eselin JA; Carter BL
    Pharmacotherapy; 1994; 14(1):60-88. PubMed ID: 8159603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophy to failure.
    Tanser PH
    J Hum Hypertens; 1994 Sep; 8 Suppl 1():S17-20. PubMed ID: 7807508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Contemporary Approach to Hypertensive Cardiomyopathy: Reversing Left Ventricular Hypertrophy.
    Bourdillon MT; Vasan RS
    Curr Hypertens Rep; 2020 Sep; 22(10):85. PubMed ID: 32889649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.